Arbutus Biopharma Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.55

+0.12 (+2.71%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,026.4% upside

Low Target $34.47

Average Target $51.25

High Target $59.24

Current Price $4.55

Current
$4.55

Target
$51.25

$34.47 $51.25 avg $59.24

Scenario Analysis

Bear Case

$34.47

657.6%

Low target

Base Case

$51.25

+1,026.4%

Avg target

Bull Case

$59.24

+1,202.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$5.10

-10.8% from high

52-Week Low

$3.04

+49.7% from low

Target vs 52W High

$51.25

+904.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+188.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%